Progesterone Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Global Progesterone Market is Segmented by Product Type (Natural and Synthetic Progesterone), Mode of Delivery (Injectable, Suspended Form, Oral, and Other Modes of Delivery), Application (Menopause, Dysfunctional Uterine Bleeding, Endometrial Cancer, Contraception, Hyperplastic Precursor Lesions, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD Million) for the Above Segments.

Progesterone Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Progesterone Market Size

progesterone market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 1.90 Billion
Market Size (2030) USD 2.91 Billion
CAGR (2025 - 2030) 8.92 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Progesterone Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Progesterone Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Progesterone Market Analysis

The Progesterone Market size is estimated at USD 1.90 billion in 2025, and is expected to reach USD 2.91 billion by 2030, at a CAGR of 8.92% during the forecast period (2025-2030).

COVID-19 had a considerable impact on the growth of the market. This is due to the effectiveness of progesterone treatment in reducing the severity of COVID-19-infected patients. In March 2021, the pilot clinical trial conducted at Cedars-Sinai Medical Center, which included 40 men, published that the use of progesterone to treat male COVID-19 patients may improve clinical outcomes for certain hospitalized men. Such studies increased the demand for progesterone treatment, thereby contributing to the market's growth during the pandemic. However, the demand for progesterone is expected to grow in the current market scenario due to the rising focus on target disorders, thereby contributing to the market's growth over the forecast period.

Rising disorders, such as abnormal uterine bleeding, menopause, endometrial cancer, hyperplastic precursor lesions, amenorrhea, and the female population suffering from these diseases, are also expected to promote growth. For instance, according to an NCBI article published in June 2021, secondary amenorrhea, occurs in approximately 3-5% of adult women globally. The report also mentioned that functional hypothalamic amenorrhea accounted for 20-30% of secondary amenorrhea cases and 3% of primary amenorrhea. Also, the NCBI article published in September 2022 mentioned that up to one-third of women will experience abnormal bleeding in their life with irregularities most commonly at menarche and menopause.

In addition, an upsurge in the incidence of breast cancer in women is anticipated to be a key growth factor, as the patient pool of breast cancer may suffer from breast tenderness, where the progesterone hormone is considered one of the treatment options. According to IARC data published in 2020, about 2.2 million new cases of breast cancer were reported across the world and were estimated to reach 3 million by 2040. Such an increase in breast cancer across the world is expected to contribute to the growth of the market over the forecast period.

The growing demand for progesterone is driven by the presence of routinely monitored formulations, technological advancements in the field of drug delivery systems, and increasing awareness among patients. Additionally, increasing product developments to meet the growing demand for progesterone are also expected to fuel the market growth. For instance, in February 2020, Besins Healthcare launched the production of Utrozhestan (progesterone) drug in Russia at the facilities of its local plant in the Yaroslavl region.

While there is an expectation for the market to experience strong growth, the lack of awareness regarding the availability of progesterone therapy in developing regions and the side effects of the therapy may restrict the market.

Progesterone Industry Overview

The progesterone market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The major market players include companies, such as Alkem Labs, Aquatic Remedies Pvt. Ltd, Bionpharma, Blubellpharma, Cadila Pharmaceuticals, Cipla Limited, Estrellas Life Sciences Private Limited, Glenmark Limited, Lupin, Mankind Pharma, and Virtus.

Progesterone Market Leaders

  1. Cadila Pharmaceuticals

  2. Alkem Labs

  3. Cipla Limited

  4. Lupin Limited

  5. Glenmark Pharmaceuticals

  6. *Disclaimer: Major Players sorted in no particular order
Progesterone Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Progesterone Market News

  • In October 2022, Sun Pharma received approval from the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) to manufacture and market progesterone sustained-release tablets (200/300/400mg) in India.
  • In September 2021, Theramex launched Bijuva/ Bijuve (1 mg estradiol / 100 mg progesterone) across Europe and the United Kingdom. Bijuva is one of the body-identical hormone therapy treatments for estrogen deficiency symptoms in post-menopausal women with an intact uterus.

Progesterone Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in the Incidence of Amenorrhea and Uterine Rupture
    • 4.2.2 Increase in Cases of Female Infertility and Breast Cancer
    • 4.2.3 Technological Advancements in the Medical Industry
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness Regarding the Availability of Hormone Therapy
    • 4.3.2 Side Effects of Progesterone
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Natural Progesterone
    • 5.1.2 Synthetic Progesterone
  • 5.2 By Mode of Delivery
    • 5.2.1 Injectable
    • 5.2.2 Suspended Form
    • 5.2.3 Oral
    • 5.2.4 Other Modes of Delivery
  • 5.3 By Application
    • 5.3.1 Menopause
    • 5.3.2 Dysfunctional Uterine Bleeding
    • 5.3.3 Endometrial Cancer
    • 5.3.4 Contraception
    • 5.3.5 Hyperplastic Precursor Lesions
    • 5.3.6 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alkem Labs
    • 6.1.2 Aquatic Remedies Pvt. Ltd
    • 6.1.3 Bionpharma
    • 6.1.4 Blubellpharma
    • 6.1.5 Cadila Pharmaceuticals
    • 6.1.6 Cipla Limited
    • 6.1.7 Estrellas Life Sciences Private Limited
    • 6.1.8 Glenmark Pharmaceuticals
    • 6.1.9 Lupin Limited
    • 6.1.10 Virtus
    • 6.1.11 Teva Pharmaceuticals
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Progesterone Industry Segmentation

Progesterone is the naturally occurring steroid hormone that is produced in the adrenal glands, ovary, and placenta. Progesterone is mainly involved in the maintenance of pregnancy, regulation of the menstrual cycle, and embryogenesis. Low progesterone levels may lead to constant breast tenderness, abdominal pain, fatigue, and even miscarriage or fetal death. During this phase, progesterone is given to the patient to prevent the aforementioned conditions. The Progesterone Market is segmented by Product Type (Natural and Synthetic Progesterone), Mode of Delivery(Injectable, Suspended form, Oral, and Other Modes of Delivery), Application( Menopause, Dysfunctional Uterine Bleeding, Endometrial Cancer, Contraception, Hyperplastic Precursor Lesions and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type Natural Progesterone
Synthetic Progesterone
By Mode of Delivery Injectable
Suspended Form
Oral
Other Modes of Delivery
By Application Menopause
Dysfunctional Uterine Bleeding
Endometrial Cancer
Contraception
Hyperplastic Precursor Lesions
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Progesterone Market Research FAQs

How big is the Progesterone Market?

The Progesterone Market size is expected to reach USD 1.90 billion in 2025 and grow at a CAGR of 8.92% to reach USD 2.91 billion by 2030.

What is the current Progesterone Market size?

In 2025, the Progesterone Market size is expected to reach USD 1.90 billion.

Who are the key players in Progesterone Market?

Cadila Pharmaceuticals, Alkem Labs, Cipla Limited, Lupin Limited and Glenmark Pharmaceuticals are the major companies operating in the Progesterone Market.

Which is the fastest growing region in Progesterone Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Progesterone Market?

In 2025, the North America accounts for the largest market share in Progesterone Market.

What years does this Progesterone Market cover, and what was the market size in 2024?

In 2024, the Progesterone Market size was estimated at USD 1.73 billion. The report covers the Progesterone Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Progesterone Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Progesterone Industry Report

Statistics for the 2025 Progesterone market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Progesterone analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.